Lilly posts results for five completed Phase 1 studies, opens three new early trialsJul 17Weekly roundup, 8 itemsEli Lillyeloralintide
Lilly posts SURPASS-CVOT results; tirzepatide compared to dulaglutide on cardiovascular eventsJul 10Weekly roundup, 8 itemsAstraZenecabaricitinib
Sign inSign in